J9262 Injection, omacetaxine mep, 0.01mg
J-Codes
Also known as: omacetaxine, Synribo
Injection of omacetaxine mepesuccinate, 0.01 milligram. A topoisomerase I inhibitor used primarily for chronic myeloid leukemia treatment.
Clinical Context
Used for patients with chronic myeloid leukemia who are resistant to tyrosine kinase inhibitors. Often used for Philadelphia chromosome-positive disease refractory to standard therapy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.